Indefinite Delivery Contract HHSN272201700053I

This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The $18 million multiple-award contract, titled "VACCINE RESEARCH CENTER CLINICAL MONITORING INITIATIVE", covers a range of clinical trials execution, regulatory support,...

The Centers for Disease Control and Prevention awarded Vanderbilt University Medical Center an indefinite delivery contract with a potential value of $86 million to provide Clinical Immunization Safety Assessment base services from September 2023 through September 2028. Under this multiple award contract vehicle, VUMC will support CDC's immunization safety monitoring and vaccine safety research efforts. CDC also issued a $6.6 million delivery order to VUMC for Clinical Immunization Safety...

The Centers for Disease Control and Prevention awarded an indefinite-delivery/indefinite-quantity contract to Children's Hospital Medical Center, doing business as Children's Home Healthcare, to provide Clinical Immunization Safety Assessment base services. The multiple award contract has a potential value of $86 million with a period of performance from September 2023 through September 2028. Two cost-no-fee delivery orders were also awarded for $1.1 million and $900,000 respectively, with...

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded an indefinite delivery contract to Pharmaceutical Research Associates Inc., doing business as PRA, with a potential value of $250 million. The contract provides for clinical trials planning and execution services in support of the Clinical Studies Network. PRA was issued a $200,000 delivery order for one base year of performance ending September 2021 to conduct clinical trial...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Contract (IDC) known as the "Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016)" to Vanderbilt University Medical Center (VUMC), a nonprofit healthcare provider. This multiple-award IDC has a potential value of $200 million and no set-aside designation. Under this IDC, the CDC has issued two firm fixed-price delivery orders...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single award Indefinite Delivery Contract to Charles River Laboratories, Inc. to provide clinical trial materials for virus vaccines with a maximum ordering value of $24,519,468.00 over a seven year period from February 2021 through February 2028. Under this contract vehicle, the agency has issued multiple firm fixed price delivery orders to Charles River for services including the production of...

The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division. With a potential value of $86M and a period of performance through September 2028, this contract will provide clinical immunization safety assessment services to the CDC. A $305K delivery order was also awarded against this contract to Columbia University for services from September 2023...

The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Emory University for clinical immunization safety assessment services. The contract has a potential value of $86 million and a period of performance from September 2023 through September 2028. No set-aside was used. Under this contract, Emory University has received two cost-no-fee delivery orders to provide clinical immunization safety assessment support to the CDC. The first delivery...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a single-award indefinite delivery indefinite quantity contract to Cerba Research USA Inc. with a potential value of $5,000,000 to provide clinical central laboratory services in support of multi-center clinical trials. Two firm fixed price delivery orders have been issued against this contract to date, one for $529,892 for laboratory services in New York from 2023-2025, and another for $1,615,094 for...

The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery/indefinite-quantity contract to Ochin, Inc. to provide Vaccine Safety Datalink services. With a potential value of $149 million and a period of performance through September 2027, this master contract will support the CDC's collaborative project with nine managed care organizations to monitor vaccine safety and conduct clinical research. Two delivery orders have been issued against this master contract to...